Heavy Drinking Recruiting Phase 4 Trials for Lorazepam (DB00186)

IndicationStatusPhase
DBCOND0042863 (Heavy Drinking)Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03235531Assessment of Valproate on Ethanol WithdrawalPrevention